Kolkata/New Delhi, Dec 9 (IBNS): 2016: Biocon's Chairperson and Managing Director Kiran Mazumdar-Shaw is enabling the showcase of a special exhibition of Science Gallery Bengaluru, Entanglement: A Dance between Art & Science at the Serendipity Arts ... India Blooms, 1 day ago
Philanthropy has to be sustainable: Kiran Mazumdar-Shaw - Livemint.com, 2 months ago
It was the best return among shares of generic drugmakers worldwide For more than two years, Kiran Mazumdar-Shaw had a quarterly date with her Twitter trolls. Every three months, after her Bengaluru-based pharmaceutical company would deliver its ...Business Standard India, 1 week ago Kiran Mazumdar-Shaw shuts up her Twitter trolls with Biocon stock rally Livemint.com, 1 week ago How One Woman Shut Up Twitter Trolls With Pharma Stock Rally (1) Yahoo! Singapore, 1 week ago Kiran Mazumdar-Shaw silences Twitter trolls with a 78% Biocon stock rally Smart Investor, 1 week ago
HYDERABAD: Biotech entrepreneur Kiran Mazumdar-Shaw has said the demonetisation of high-value currency notes is an opportunity to leapfrog into a digital cashless economy, even as she called for a effective monitoring to prevent accumulation of ...Economic Times, 2 weeks ago
Beyond the urban household, India's poor are in dire need of access to health care, and these startups are tackling the challenge Image: Shutterstock Neurosynatpic has built a patented digital health solution — a combination of software ...Forbes India, 1 month ago
Shares of Reliance Industries today fell 2.5 per cent after the company reported 23 per cent decline in second quarter net profit. The stock, even after a positive opening, failed to hold on to the gains and slipped 2.51 per cent to Rs 1,061.10 on ...Hindu Business Line, 1 month ago Biocon net up 52% in second quarter Yahoo! India, 1 month ago Biocon Q2 net profit of Rs 146.7 cr Moneycontrol.com, 1 month ago Biocon profit up 52% to Rs.147 crore in Q2 Livemint.com, 1 month ago
The firm, along with Mylan NV, is developing four biosimilars: pegfilgrastim, trastuzumab, adalimumab and insulin glargine Hyderabad: Bio-pharmaceutical company Biocon Ltd on Friday said it expects to see its first set of biosimilar products hit the ...Livemint.com, 1 month ago
Half Year 2017 Biocon Ltd Earnings Call TEXT version of Transcript ================================================================================ Corporate Participants ...Yahoo! Finance, 1 month ago
Biocon's facility. Photo: Company's website Biocon hit a fresh record high of Rs 1,020, up 4% on BSE in early morning trade, after the company posted robust 52% year on year (YoY) jump in consolidated net profit at Rs 147 crore for the quarter ...Smart Investor, 1 month ago
Biocon Q2 FY17 Revenue Up 21% EBITDA Up 45% Revenues at Rs 992 Crs.; EBITDA at Rs 277 Crs.; Net Profit at Rs 147 Crs.
Biocon Ltd (BSE code: 532523, NSE: BIOCON), Asia's premier biopharmaceuticals company, announced today its consolidated financial results for the second quarter ended on September 30th, 2016. Commenting on the quarterly performance and highlights, ...Biocon, 1 month ago Biocon Q2 FY17 Revenue Up 21%; EBITDA Up 45% Businessworld India, 1 month ago Biocon Q2 FY17 Revenue Up 21 EBITDA Up 45 Pharma Focus Asia, 1 month ago
More from: , AndhraNews.net...and 1 other sources
UE LifeSciences, a mobile health technology developer of iBreastExam, has raised follow-on strategic investment of $1.2 million (approximately Rs 8 crore) led by Kiran Mazumdar-Shaw, Chairman and Managing Director of Biocon. Its existing investor ...Yourstory.in, 2 months ago UE LifeSciences raises $1.2 mn to scale up operations in India & expand innovation pipeline in mobile health devices segment PharmaBiz, 2 months ago
on your WebpageAdd Widget >Get your members hooked!